SC 13G/A

AMENDMENT NO. 12 TO SCHEDULE 13G

Company: Corbus Pharmaceuticals Holdings, Inc.
Filed: February 12, 2021
Accession Number: 0001213900-21-008829

View Document ↗ View on SEC.gov ↗